Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by NuBeeInvestoron Sep 12, 2019 9:49am
93 Views
Post# 30119461

Doesn't share price below .10 CDN hurt the private placement

Doesn't share price below .10 CDN hurt the private placement
Assuming the private placement is still open and they have not yet raised the $5M USD, who in their right mind would take part in it at this point when you can get shares cheaper on the open market. Even at .10 on the open market it would be better than the private placement because shares in the private placement would be locked in for 4 months. Am I missing something? You would think management would release some positive news to get the share price over .10 to incentivize people with the private placement. The only thing I could think of is that the private placement makes sense for someone wanting to drop big dollars ($100k+) in the private placement that would not fill their order in the open market below .10. Regardless, it's definitely not good for raising capital if the private placement price is above the current share price especially with no warrants and a 4 month holding period.
Bullboard Posts